S. Lee

发表

Immunological Markers, Prognostic Factors and Challenges Following Curative Treatments for Hepatocellular Carcinoma

J. Jang, S. Bae, S. Yoon, 2021, International journal of molecular sciences.

A comparative study of sorafenib and metronomic chemotherapy for Barcelona Clinic Liver Cancer-stage C hepatocellular carcinoma with poor liver function

Myeong Jun Song, J. Jang, S. Bae, 2017, Clinical and molecular hepatology.

Cardiac diastolic dysfunction predicts poor prognosis in patients with decompensated liver cirrhosis

Myeong Jun Song, H. Ahn, S. Lee, 2018, Clinical and molecular hepatology.

Distinct Patterns of HBV Integration and TERT Alterations between in Tumor and Non-Tumor Tissue in Patients with Hepatocellular Carcinoma

L. Roberts, Tae-Min Kim, J. Jang, 2021, International journal of molecular sciences.

STX0119 ameliorates arthritis in SKG mice via inhibiting T helper 17

M. Cho, Seung Hoon Lee, S. Kim, 2016, Tissue Engineering and Regenerative Medicine.

Serial Monitoring of Immune Markers Being Represented Regulatory T Cell/T Helper 17 Cell Ratio: Indicating Tolerance for Tapering Immunosuppression after Liver Transplantation

S. Bae, S. Yoon, B. Chung, 2018, Front. Immunol..

A decrease in functional microbiomes represented as Faecalibacterium affects immune homeostasis in long-term stable liver transplant patients

J. Jang, S. Bae, S. Yoon, 2022, Gut microbes.

A Real-World Comparative Analysis of Lenvatinib and Sorafenib as a Salvage Therapy for Transarterial Treatments in Unresectable HCC

J. Jang, S. Bae, S. Yoon, 2020, Journal of clinical medicine.

Comparative Analysis of Lenvatinib and Hepatic Arterial Infusion Chemotherapy in Unresectable Hepatocellular Carcinoma: A Multi-Center, Propensity Score Study

J. Jang, S. Bae, S. Yoon, 2021, Journal of clinical medicine.

Real-life experience of ledipasvir and sofosbuvir for HCV infected Korean patients: a multicenter cohort study

Myeong Jun Song, J. Jang, S. Bae, 2022, The Korean journal of internal medicine.

Sustained off therapy response after peglyated interferon favours functional cure and no disease progression in chronic hepatitis B

J. Jang, S. Bae, S. Yoon, 2020, Liver international : official journal of the International Association for the Study of the Liver.

Diffusion-Weighted Magnetic Resonance Imaging in Hepatocellular Carcinoma as a Predictor of a Response to Cisplatin-Based Hepatic Arterial Infusion Chemotherapy

J. Jang, S. Bae, S. Yoon, 2020, Frontiers in Oncology.

FK506 and Lactobacillus acidophilus ameliorate acute graft-versus-host disease by modulating the T helper 17/regulatory T-cell balance

Min-jung Park, Jin Seok Woo, M. Cho, 2021, Journal of translational medicine.

Diagnostic performance of serum exosomal miRNA-720 in hepatocellular carcinoma

J. Jang, S. Bae, S. Yoon, 2022, Journal of liver cancer.

Safety and effectiveness of direct-acting antivirals in patients with chronic hepatitis C and chronic kidney disease

Myeong Jun Song, J. Jang, S. Bae, 2022, The Korean journal of internal medicine.

Real-Life Experience of mTOR Inhibitors in Liver Transplant Recipients in a Region Where Living Donation Is Predominant

J. Jang, S. Yoon, P. Sung, 2021, Frontiers in Pharmacology.

Safety and efficacy of tenofovir in chronic hepatitis B-related decompensated cirrhosis

Myeong Jun Song, I. Song, S. Kim, 2017, World journal of gastroenterology.

An Immunological Perspective on the Mechanism of Drug Induced Liver Injury: Focused on Drugs for Treatment of Hepatocellular Carcinoma and Liver Transplantation

J. Jang, S. Bae, S. Yoon, 2023, International journal of molecular sciences.

Patient-Derived Avatar Mouse Model to Predict the Liver Immune Homeostasis of Long-Term Stable Liver Transplant Patients

J. Jang, S. Bae, S. Yoon, 2022, Frontiers in Immunology.

Combination Treatment With Metformin and Tacrolimus Improves Systemic Immune Cellular Homeostasis by Modulating Treg and Th17 Imbalance

J. Jang, S. Bae, S. Yoon, 2021, Frontiers in Immunology.

Comparing various scoring system for predicting overall survival according to treatment modalities in hepatocellular carcinoma focused on Platelet-albumin-bilirubin (PALBI) and albumin-bilirubin (ALBI) grade: A nationwide cohort study

Myeong Jun Song, Misun Park, S. Lee, 2019, PloS one.

Use of M2BPGi in HCC patients with TACE

J. Jang, S. Bae, S. Yoon, 2021, Journal of Gastroenterology and Hepatology.

Significance of TERT Genetic Alterations and Telomere Length in Hepatocellular Carcinoma

J. Jang, S. Bae, S. Yoon, 2021, Cancers.

Real-World Outcomes of Nivolumab in Patients With Unresectable Hepatocellular Carcinoma in an Endemic Area of Hepatitis B Virus Infection

J. Jang, S. Bae, S. Yoon, 2020, Frontiers in Oncology.

Sorafenib for advanced hepatocellular carcinoma provides better prognosis after liver transplantation than without liver transplantation

Myeong Jun Song, J. Jang, S. Bae, 2021, Hepatology International.

Reactivation of resolved hepatitis B after daratumumab for multiple myeloma.

J. Jang, S. Yoon, P. Sung, 2021, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Immune-mediated liver injury represented as overlap syndrome after SARS-CoV-2 vaccination

P. Sung, J. Kwon, S. Lee, 2022, Journal of Hepatology.

Long-term Clinical Outcomes and Predictive Factors for Living-donor Liver Transplant Recipients With Biliary Strictures

J. Jang, S. Yoon, I. Lee, 2022, Transplantation.

Risk factors of biliary intervention by imaging after living donor liver transplantation.

J. Jang, S. Bae, S. Yoon, 2016, World journal of gastroenterology.

Preferential Expression of Programmed Death Ligand 1 Protein in Tumor-Associated Macrophages and Its Potential Role in Immunotherapy for Hepatocellular Carcinoma

W. Hur, J. Jang, S. Bae, 2021, International journal of molecular sciences.

HMGB1/RAGE induces IL-17 expression to exaggerate inflammation in peripheral blood cells of hepatitis B patients

M. Cho, J. Choi, H. Kim, 2015, Journal of Translational Medicine.

Clinical characteristics of portal hypertension complicated by gastroesophageal varices in patients with my- eloproliferative neoplasms

J. Jang, S. Bae, S. Yoon, 2019, Clinical and molecular hepatology.

A Real-World Comparative Study of Microwave and Radiofrequency Ablation in Treatment-Naïve and Recurrent Hepatocellular Carcinoma

D. Chung, S. Cho, S. Lee, 2022, Journal of clinical medicine.

Chemoembolization combined radiofrequency ablation vs. chemoembolization alone for treatment of beyond the Milan criteria viable hepatocellular carcinoma (CERFA): study protocol for a randomized controlled trial

Dong Jae Shim, J. Jang, S. Bae, 2023, Trials.

Autoimmune liver disease represented as primary biliary cholangitis after SARS-CoV-2 infection: A need for population-based cohort study

S. Lee, N. Yoon, Junghee kwon, 2022, Clinical and molecular hepatology.

A Real-World Comparative Analysis of Atezolizumab Plus Bevacizumab and Transarterial Chemoembolization Plus Radiotherapy in Hepatocellular Carcinoma Patients with Portal Vein Tumor Thrombosis

Myeong Jun Song, Dong Jae Shim, J. Jang, 2023, Cancers.

Successful Sequential Therapy Involving Regorafenib after Failure of Sorafenib in a Patient with Recurrent Hepatocellular Carcinoma after Liver Transplantation

J. Jang, S. Bae, S. Yoon, 2020, Journal of liver cancer.

Use of M2BPGi in HCC patients with TACE

J. Jang, S. Bae, S. Yoon, 2021, Journal of gastroenterology and hepatology.

Long-Term HBsAg Titer Kinetics with Entecavir/Tenofovir: Implications for Predicting Functional Cure and Low Levels

S. Lee, J. W. Jang, Soon Woo Nam, 2024, Diagnostics.

Switching from tenofovir disoproxil fumarate to tenofovir alafenamide in virologically suppressed patient with chronic hepatitis B.

J. Jang, S. Bae, P. Sung, 2024, Journal of gastroenterology and hepatology.

Differential HBV replicative markers and covalently closed circular DNA transcription in immune-active chronic hepatitis B with and without HBeAg.

P. Sung, J. Choi, J. Kim, 2024, Liver international : official journal of the International Association for the Study of the Liver.

Differential liver function at cessation of atezolizumab-bevacizumab versus lenvatinib in HCC: a multicenter, propensity-score matched comparative study

Myeong Jun Song, S. Bae, P. Sung, 2024, Frontiers in oncology.